From: Depression diagnoses following the identification of bipolar disorder: costly incongruent diagnoses
 | Cohort |  |  | |||
---|---|---|---|---|---|---|
 | NIDD (N = 6581) | IDD (N = 1400) | Uni- variate | Multivariate | ||
Demographic Variables: | Â | Â | Â | Â | p | p |
Men, n, % | 2378 | 36.13% | 391 | 27.93% | <.0001 | Â |
Age, mean, SD | 40.62 | 11.02 | 39.73 | 10.97 | .0064 | .0317 |
Region | Â | Â | Â | Â | Â | Â |
   Northeast, n, % | 747 | 11.35% | 213 | 15.21% | <.0001 |  |
   South, n, % | 2781 | 42.26% | 570 | 40.71% | .2879 | .0845 |
   West, n, % | 860 | 13.07% | 159 | 11.36% | .0816 |  |
   Midwest, n, % | 2193 | 33.32% | 458 | 32.71% | .6605 |  |
Plan Type | Â | Â | Â | Â | Â | Â |
   Commercial, n, % | 6232 | 94.70% | 1344 | 96.00% | .0437 |  |
   Medicaid, n, % | 349 | 5.30% | 56 | 4.00% | .0437 |  |
Baseline Variables: | Â | Â | Â | Â | Â | Â |
Baseline Unipolar Dx, n, % | 886 | 13.46% | 936 | 66.86% | <.0001 | <.0001 |
Number of Unipolar Dxsa | 0.95 | 3.24 | 8.96 | 11.60 | <.0001 | <.0001 |
Total Costsa | 9056.62 | 18371.86 | 13448.57 | 20021.63 | <.0001 | .0163 |
M H Ambulatory Costa | 835.59 | 1704.91 | 1999.31 | 4421.06 | <.0001 | <.0001 |
Non-MH Ambulatory Costa | 2089.39 | 4000.50 | 2835.56 | 5239.78 | <.0001 | .0652 |
Mental Health ER Costa | 48.42 | 304.59 | 96.40 | 525.63 | .001 | Â |
Non-MH ER Costa | 206.93 | 845.65 | 293.98 | 1041.55 | .0034 | Â |
MH Inpatient Costa | 793.66 | 3428.65 | 2141.36 | 7325.41 | <.0001 | Â |
Non-MH Inpatient Costa | 1752.31 | 17979.46 | 1658.32 | 12441.45 | .8141 | Â |
MH Medication Costa | 1745.42 | 1909.65 | 2153.20 | 2032.10 | <.0001 | .018 |
Total Medication Costa | 2836.37 | 2882.69 | 3545.40 | 3370.89 | <.0001 | Â |
Number of Psychotherapy Sessionsa | 5.92 | 9.43 | 13.14 | 13.77 | <.0001 | Â |
Antidepressant Day Supplya | 186.58 | 196.25 | 276.30 | 209.07 | <.0001 | <.0001 |
Lithium Day Supplya | 55.36 | 111.00 | 31.05 | 81.58 | <.0001 | <.0001 |
Benzodiazepine Day Supplya | 64.38 | 123.73 | 98.61 | 144.33 | <.0001 | .0015 |
Anticonvulsants Day Supplya | 137.94 | 171.75 | 132.97 | 162.30 | .3035 | <.0001 |
Antidepressant Monotherapyb | 0.082 | 0.27 | 0.10 | 0.30 | .031 | .0163 |
Number of Claims w/ADHD Dxa | 0.21 | 1.51 | 0.29 | 2.14 | .2126 | .0716 |
Number of Claims with Non-MH Unique Dxa | 12.62 | 9.38 | 15.32 | 10.47 | <.0001 | .0403 |
Index BP Dx on Inpatient Claim, n, % | 312 | 4.74% | 163 | 11.64% | <.0001 | <.0001 |
BP Diagnosis on ER Claim, n, % | 273 | 4.15% | 28 | 2.00% | .0001 | .0225 |
Index BP Dx Mixed Episode, n, % | 1208 | 18.36% | 222 | 15.86% | .0269 | .0584 |
Index BP Dx Unspecified Episode, n, % | 3020 | 45.89% | 574 | 41.00% | .0008 | .0094 |
Charlson Comorbidity Indexa | 0.51 | 1.14 | 0.58 | 1.19 | .042 | Â |